Magnolia Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.49M Buy
4,885
+2,062
+73% +$2.09M 0.88% 31
2025
Q4
$3.03M Buy
2,823
+96
+4% +$91.8K 0.64% 42
2025
Q3
$2.08M Buy
2,727
+15
+0.6% +$11.2K 0.54% 51
2025
Q2
$2.11M Sell
2,712
-12
-0.4% -$9.32K 0.53% 47
2025
Q1
$2.25M Sell
2,724
-473
-15% -$394K 0.61% 42
2024
Q4
$2.47M Buy
3,197
+2,738
+597% +$2.27M 0.64% 42
2024
Q3
$407K Buy
+459
New +$413K 0.2% 105
2023
Q3
Sell
-2,262
Closed -$1.06M 113
2023
Q2
$1.06M Buy
2,262
+102
+5% +$42.8K 0.53% 57
2023
Q1
$742K Buy
2,160
+8
+0.4% +$2.7K 0.38% 68
2022
Q4
$787K Sell
2,152
-1
-0% -$355 0.52% 56
2022
Q3
$696K Buy
+2,153
New +$682K 0.59% 55
2022
Q2
Sell
-783
Closed -$224K 160
2022
Q1
$224K Buy
+783
New +$202K 0.09% 166

Other funds holding LLY

Magnolia Capital Advisors's LLY Position: Q1 2026 in Review

Magnolia Capital Advisors increased its Eli Lilly (LLY) stake by 73% in Q1 2026, buying an estimated $2.09M and bringing the position to 4,885 shares worth $4.49M. The position accounts for 0.88% of the portfolio, ranked #31.

Magnolia Capital Advisors first reported a position in LLY in Q1 2022 and has held it in 12 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Magnolia Capital Advisors held 4,885 shares of Eli Lilly worth $4.49M as of Q1 2026.
  • Magnolia Capital Advisors bought 2,062 Eli Lilly shares in Q1 2026, an estimated $2.09M.
  • Eli Lilly made up 0.88% of Magnolia Capital Advisors's portfolio in Q1 2026, its #31 holding.
  • Magnolia Capital Advisors first reported a position in Eli Lilly in Q1 2022 and has held it in 12 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Magnolia Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.